June 19, 2017
The Federation of Pharmaceutical Manufacturers’ Associations of Japan’s (FPMAJ) committee on drug pricing affairs issued a report on generic drugs and basic drugs on June 16. It points out problems with the current price-band grouping rule for listed generics, saying...read more